Efficacy of Vedolizumab for Inflammatory Bowel Disease in the Setting of DiGeorge Syndrome

J Pediatr Gastroenterol Nutr. 2019 May;68(5):e88. doi: 10.1097/MPG.0000000000002322.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Child
  • DiGeorge Syndrome / complications*
  • Gastrointestinal Agents / therapeutic use*
  • Humans
  • Inflammatory Bowel Diseases / congenital
  • Inflammatory Bowel Diseases / drug therapy*
  • Male

Substances

  • Antibodies, Monoclonal, Humanized
  • Gastrointestinal Agents
  • vedolizumab